Decreased substance P levels in rectal biopsies from patients with slow transit constipation. 1996

K Tzavella, and R L Riepl, and A G Klauser, and W A Voderholzer, and N E Schindlbeck, and S A Müller-Lissner
Medizinische Klinik, Klinikum Innenstadt, University of Munich, Germany.

OBJECTIVE Previous studies in patients with chronic constipation found abnormalities in the nervous tissue of the large intestine, predominantly in the muscularis externa. Since there is evidence that the nervous system of mucosa and submucosa is also involved in the control of colonic motility we investigated the contents of vasoactive intestinal polypeptide (VIP), somatostatin and substance P in rectal biopsies of patients with slow colonic transit constipation. METHODS Twenty-two patients (17 females, 5 males) with chronic slow transit constipation (oro-anal transit with radio-opaque markers on high fibre diet > 70 h) and long-term use of laxatives, and 20 controls (12 females, 8 males) with no history of constipation, were included in this study. Large rectal biopsy specimens including the submucosa were obtained from 5 cm above the dentate line and frozen in liquid nitrogen. After microdissection of the biopsies into mucosa and submucosa the neuropeptides were extracted by boiling and homogenizing the tissue in acetic acid and determined using validated radioimmunoassays. RESULTS Patients with slow transit constipation showed, compared to healthy controls, significantly lower levels of the excitatory neurotransmitter substance P in the mucosa and submucosa of rectal biopsies. There was no difference between the two groups concerning the levels of the inhibitory neurotransmitters, VIP and somatostatin. CONCLUSIONS Slow transit constipation is associated with abnormalities of the substance P content of the enteric nervous system of mucosa and submucosa. This seems not to be related to chronic laxative use, since anthranoids cause a reduction in the levels of inhibitory neurotransmitters (VIP, somatostatin), but not of substance P, in the rat colon.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D012007 Rectum The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL. Rectums
D003248 Constipation Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections. Colonic Inertia,Dyschezia
D005260 Female Females
D005772 Gastrointestinal Transit Passage of food (sometimes in the form of a test meal) through the gastrointestinal tract as measured in minutes or hours. The rate of passage through the intestine is an indicator of small bowel function. GI Transit,GI Transits,Gastrointestinal Transits,Transit, GI,Transit, Gastrointestinal,Transits, GI,Transits, Gastrointestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies

Related Publications

K Tzavella, and R L Riepl, and A G Klauser, and W A Voderholzer, and N E Schindlbeck, and S A Müller-Lissner
July 2011, Pediatric surgery international,
K Tzavella, and R L Riepl, and A G Klauser, and W A Voderholzer, and N E Schindlbeck, and S A Müller-Lissner
January 2000, Gastroenterology,
K Tzavella, and R L Riepl, and A G Klauser, and W A Voderholzer, and N E Schindlbeck, and S A Müller-Lissner
July 1997, Metabolism: clinical and experimental,
K Tzavella, and R L Riepl, and A G Klauser, and W A Voderholzer, and N E Schindlbeck, and S A Müller-Lissner
January 1998, Upsala journal of medical sciences,
K Tzavella, and R L Riepl, and A G Klauser, and W A Voderholzer, and N E Schindlbeck, and S A Müller-Lissner
August 2002, Current treatment options in gastroenterology,
K Tzavella, and R L Riepl, and A G Klauser, and W A Voderholzer, and N E Schindlbeck, and S A Müller-Lissner
March 2001, Gastroenterology clinics of North America,
K Tzavella, and R L Riepl, and A G Klauser, and W A Voderholzer, and N E Schindlbeck, and S A Müller-Lissner
August 2001, Current treatment options in gastroenterology,
K Tzavella, and R L Riepl, and A G Klauser, and W A Voderholzer, and N E Schindlbeck, and S A Müller-Lissner
January 2022, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
K Tzavella, and R L Riepl, and A G Klauser, and W A Voderholzer, and N E Schindlbeck, and S A Müller-Lissner
April 2019, Zentralblatt fur Chirurgie,
K Tzavella, and R L Riepl, and A G Klauser, and W A Voderholzer, and N E Schindlbeck, and S A Müller-Lissner
February 2009, Journal of pediatric surgery,
Copied contents to your clipboard!